Today: 31 January 2026
Subscribe
Browse Category

Business News News 1 November 2025 - 4 November 2025

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Background: Novo vs. Pfizer in the Weight-Loss Drug Race The fight for Metsera is driven by fierce competition in GLP-1 obesity drugs. Novo Nordisk is the maker of Wegovy/Ozempic, and Eli Lilly’s drugs recently overtook Wegovy in US market share Reuters. Novo’s new CEO Mike Doustdar and the company’s controlling foundation have pushed for bolder moves after days of sliding…
4 November 2025
···
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact, DENN hit a 52-week low of $2.85 earlier in the year Marketbeat, reflecting investors’ pessimism about growth prospects. By late…
4 November 2025
····
Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

Amazon’s $38 Billion OpenAI Deal Makes Bezos $10 B Richer and Ignites the AI Cloud Wars

AWS and OpenAI Ink a $38 Billion Cloud Partnership Amazon Web Services and OpenAI unveiled a multi-year cloud computing deal that ranks among the largest ever in tech. Under the agreement – valued at $38 billion over seven years – OpenAI will run and scale its advanced AI workloads on AWS’s “world-class infrastructure” starting immediately Aboutamazon. In practical terms, AWS is provisioning…
4 November 2025
····
Nokia’s 2025 Comeback: Nvidia’s $1B AI Stake, 5G Growth & Surging Stock

Nokia’s 2025 Comeback: Nvidia’s $1B AI Stake, 5G Growth & Surging Stock

Latest News & Catalysts (Early Nov 2025) In the first week of November 2025, Nokia has dominated tech stock headlines. The biggest catalyst was Nvidia’s announcement (Oct 28, 2025) of a $1.0 billion equity investment in Nokia Reuters. Nvidia will buy ~166 million new Nokia shares at $6.01 each, giving it a 2.9% stake Reuters. This partnership is focused on jointly…
3 November 2025
····
FuboTV’s Big Score: Disney Hulu Deal and Surprise Profit Spark Stock Surge

FuboTV’s Big Score: Disney Hulu Deal and Surprise Profit Spark Stock Surge

FuboTV Stock Rallies on Earnings and Disney Deal FuboTV’s stock is on the move after a one-two punch of strong earnings and a transformational Disney partnership. As of November 3, 2025, FUBO shares traded around $3.90, up roughly 5% from the prior close Investing. The latest Q3 earnings surprise – featuring better-than-expected revenue and a swing to adjusted profit –…
3 November 2025
····
Google’s $3 Billion AI Bet on a Bitcoin Miner – Cipher Mining’s Q3 Bombshell Deals

Google’s $3 Billion AI Bet on a Bitcoin Miner – Cipher Mining’s Q3 Bombshell Deals

Cipher Mining’s “Transformative” Q3 Results Cipher Mining’s third quarter 2025 financial results underscore a company in transition. Revenue came in at $72 million, more than triple the year-ago quarter (up 213%) Etfchannel. This jump was largely thanks to new mining capacity like the Black Pearl site ramping up Bitcoin production and efficiency Etfchannel. Despite the rapid growth, the company recorded a…
3 November 2025
···
Off-the-Shelf CAR-T Triumph: Caribou’s Breakthrough Results Spark Stock Surge

Off-the-Shelf CAR-T Triumph: Caribou’s Breakthrough Results Spark Stock Surge

Caribou’s Game-Changing CAR-T Results Caribou Biosciences – a clinical-stage biotech focusing on genome-edited cell therapies – stunned the biotech world with new data on November 3, 2025, showcasing that its off-the-shelf CAR-T cell treatments can achieve remission rates on par with personalized CAR-T therapies Statnews. In an early-morning webcast, Caribou revealed Phase 1 trial outcomes from two programs: vispa-cel for…
3 November 2025
··
DroneShield’s Wild Ride: 400% Defense-Tech Surge, October Crash, and a $25 Million Deal – What’s Next?

DroneShield’s Wild Ride: 400% Defense-Tech Surge, October Crash, and a $25 Million Deal – What’s Next?

From 10× Surge to 30% Plunge: DroneShield’s Rollercoaster Few stocks illustrate 2025’s defense-tech frenzy better than DroneShield. The Sydney-based counter-drone specialist entered the year as a little-known penny stock (around A$0.60), then rode a wave of war-driven demand to an all-time high of A$6.70 in October Businessnewsaustralia. By early autumn, DroneShield had gained well over 1000% in 2025 – a…
3 November 2025
····
Opendoor’s Wild 2025 Ride – 1600% Meme Surge, New CEO & the Future of iBuying

Opendoor’s Wild 2025 Ride – 1600% Meme Surge, New CEO & the Future of iBuying

Stock Price & 2025 Performance Opendoor’s stock has been on a rollercoaster ride in 2025. After languishing under $1 per share in early summer (flirting with Nasdaq delisting), OPEN skyrocketed as retail traders piled in. By mid-September, shares hit a 52-week high of $10.87, marking a stunning ~1,600% rise in just a few months ts2.tech. This meme-fueled rally vastly outpaced…
2 November 2025
···
Core Scientific (CORZ) Skyrockets on Bitcoin Boom and $9B Deal Drama – Latest News & Analysis

Core Scientific (CORZ) Skyrockets on Bitcoin Boom and $9B Deal Drama – Latest News & Analysis

Stock Price & Recent Performance Core Scientific’s stock has been on a tear in 2025. It closed at $21.54 on October 31 (Friday) Finviz, capping a weekly jump after the shareholder vote drama. At this level, CORZ trades just a few percent shy of its record high (~$22.12) and has skyrocketed ~250% from its 52-week low Finviz. The rally has…
2 November 2025
····
Pfizer Stock Surges on Trump’s Drug Price Deal & $7B Obesity Gamble – Is This the Comeback Investors Hoped For?

Pfizer Stock Surges on Trump’s Drug Price Deal & $7B Obesity Gamble – Is This the Comeback Investors Hoped For?

Technical Analysis – Levels to Watch From a technical perspective, Pfizer’s stock has been basing in the low-to-mid $20s and has yet to break out of its longer-term downtrend. The 52-week range is roughly $20.92 to $30.43 ts2.tech, and the late-September rally stalled out near the upper-$20s – a zone that now acts as an overhead resistance (around $26–$27). Notably,…
1 November 2025
···
Buffett’s Berkshire Stuns with Record Cash Hoard and Profit Surge Ahead of CEO Exit

Buffett’s Berkshire Stuns with Record Cash Hoard and Profit Surge Ahead of CEO Exit

Q3 2025 Earnings Highlights Berkshire Hathaway delivered strong third-quarter results that surprised to the upside. Operating earnings — Buffett’s preferred metric which excludes investment swings — surged to $13.485 billion (about $9,376 per Class A share), up from $10.09 billion a year earlier Reuters. This ~34% jump in operating profit was aided significantly by a rebound in insurance performance and favorable foreign exchange…
1 November 2025
···
1 … 64 65 66 67 68 … 80

Stock Market Today

  • Crypto Tokens Drop 6% Amid Weekend Liquidations, Ether Loses $385 Million
    January 31, 2026, 1:23 PM EST. Cryptocurrency markets continued their weekend decline as major tokens and high-beta altcoins faced significant liquidations. Ether, the second-largest cryptocurrency, experienced approximately $385 million in futures liquidations within 24 hours, the highest among assets, following a sharp price drop tied to a broader risk-off sentiment. Bitcoin liquidations reached about $188 million, with Solana and XRP each seeing over $45 million wiped out. The selloff predominantly affected long positions, reflecting traders caught on the wrong side after weeks of range-bound trading. Tokenized commodities like blockchain-based silver also faced notable liquidations, highlighting crypto's growing role in macro trading during stress periods. Overall, nearly $974 million was lost, forcing over 240,000 traders out. Prices fell, with Bitcoin nearing the low $80,000s and altcoins declining faster due to leverage sensitivity, marking a mechanical market reset rather than panic.
Go toTop